The association between aspirin use and immune-related adverse events in specific cancer patients receiving ICIs therapy: analysis of the FAERS database

Background: The promise of immune checkpoint inhibitors (ICIs) therapy in cancer treatment is tempered by the occurrence of immune-related adverse events (irAEs). Many patients undergoing ICIs also take aspirin, but the association between aspirin and irAEs is not well understood. Methods: This stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Huaju, Liu, Zheran, Li, Ruidan, Huang, Rendong, Peng, Xingchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686414/
https://www.ncbi.nlm.nih.gov/pubmed/38035011
http://dx.doi.org/10.3389/fphar.2023.1259628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686414/
https://www.ncbi.nlm.nih.gov/pubmed/38035011
http://dx.doi.org/10.3389/fphar.2023.1259628

Ejemplares similares